# A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus

> **NCT06202079** · PHASE2 · COMPLETED · sponsor: **Gan and Lee Pharmaceuticals, USA** · enrollment: 179 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** GZR4 Injection
- **DRUG:** Insulin Degludec

## Key facts

- **NCT ID:** NCT06202079
- **Lead sponsor:** Gan and Lee Pharmaceuticals, USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-11
- **Primary completion:** 2024-07-13
- **Final completion:** 2024-08-08
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06202079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06202079, "A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06202079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*